Pancreatic Cancer Research

ResearcherAbramson Cancer CenterActive in the last 2 years

Rong Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4018-381X; OpenAlex author ID A5069305433; NIH RePORTER profile ID 7614853. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 6)
Trials
0
Grants
1
Labs led
1
Collaborators
14
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper, 1 grant · 2023: 1 paper · 2024: 1 paper · 2025: 3 papers · 2026: 1 paper

Papers 9

  1. Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular Analyses. Last author DOI 10.1158/2767-9764.crc-26-0443↗
  2. Modeling tumor dynamics and predicting response to therapies in a murine pancreatic cancer model. Co-author DOI 10.1038/s41540-025-00593-z↗
  3. Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. Last author DOI 10.1158/1078-0432.ccr-24-4049↗
  4. MRI Detection of PDAC Response to KRAS Inhibitor Therapy—Response Co-author DOI 10.1158/1078-0432.ccr-25-1932↗
  5. Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study Last author DOI 10.1101/2024.12.24.630138↗
  6. Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Ortho… Last author DOI 10.1007/s11307-023-01824-7↗
  7. DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models. Last author DOI 10.3390/cancers14164017↗
  8. Respiratory Motion Mitigation and Repeatability of Two Diffusion-Weighted MRI Methods Applied to a Murine Model of Spontaneous Pancreatic Cancer. Co-author DOI 10.3390/tomography7010007↗
  9. Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/1078-0432.ccr-18-2276↗

Grants 1

  1. Penn Quantitative MRI Resource for Pancreatic Cancer U24CA231858↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mark Alan Rosen · 7 shared papers, 1 shared grant, 2019–2026 · strength 1.79
  2. Stephen Pickup · 7 shared papers, 2019–2026 · strength 1.26
  3. Peter James O'Dwyer · 4 shared papers, 1 shared grant, 2019–2026 · strength 1.16
  4. Mamta Gupta · 4 shared papers, 2022–2026 · strength 0.77
  5. Jianbo Cao · 4 shared papers, 2019–2023 · strength 0.62
  6. Ernesto A. B. F. Lima · 2 shared papers, 2025 · strength 0.61
  7. Thomas E. Yankeelov · 2 shared papers, 2025 · strength 0.61
  8. Thomas Benjamin Karasic · 3 shared papers, 2022–2026 · strength 0.54
  9. Krithik Vishwanath · 1 shared paper, 2025 · strength 0.28
  10. Samantha B. Kemp · 1 shared paper, 2025 · strength 0.23
  11. Margo Orlen · 1 shared paper, 2025 · strength 0.23
  12. Ben Z. Stanger · 1 shared paper, 2025 · strength 0.23
  13. Fang Liu · 1 shared paper, 2024 · strength 0.18
  14. Miguel Romanello Joaquim · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.